JP2005529603A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005529603A5 JP2005529603A5 JP2004512780A JP2004512780A JP2005529603A5 JP 2005529603 A5 JP2005529603 A5 JP 2005529603A5 JP 2004512780 A JP2004512780 A JP 2004512780A JP 2004512780 A JP2004512780 A JP 2004512780A JP 2005529603 A5 JP2005529603 A5 JP 2005529603A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- individual
- diabetic
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 6
- 229920001184 polypeptide Polymers 0.000 claims 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 206010018429 Glucose tolerance impaired Diseases 0.000 claims 3
- 206010022489 Insulin Resistance Diseases 0.000 claims 3
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 208000001280 Prediabetic State Diseases 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 210000000663 muscle cell Anatomy 0.000 claims 1
- 201000009104 prediabetes syndrome Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38871602P | 2002-06-13 | 2002-06-13 | |
| PCT/US2003/018976 WO2003105879A1 (en) | 2002-06-13 | 2003-06-13 | Compositions and methods for preventing, treating and diagnosing diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005529603A JP2005529603A (ja) | 2005-10-06 |
| JP2005529603A5 true JP2005529603A5 (enExample) | 2006-07-27 |
Family
ID=29736528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004512780A Pending JP2005529603A (ja) | 2002-06-13 | 2003-06-13 | 糖尿病を予防、治療、および診断するための組成物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20060210974A1 (enExample) |
| EP (1) | EP1511506A4 (enExample) |
| JP (1) | JP2005529603A (enExample) |
| AU (1) | AU2003238232A1 (enExample) |
| WO (1) | WO2003105879A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| US8034822B2 (en) | 2006-03-08 | 2011-10-11 | Takeda San Diego, Inc. | Glucokinase activators |
| JP5386350B2 (ja) | 2006-05-31 | 2014-01-15 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体 |
| US8163779B2 (en) | 2006-12-20 | 2012-04-24 | Takeda San Diego, Inc. | Glucokinase activators |
| WO2008116107A2 (en) | 2007-03-21 | 2008-09-25 | Takeda San Diego, Inc. | Piperazine derivatives as glucokinase activators |
| KR101666228B1 (ko) | 2007-09-28 | 2016-10-13 | 인트렉손 코포레이션 | 생물치료학적 분자를 발현시키기 위한 치료학적 유전자-스위치 작제물 및 생물반응기, 및 이의 용도 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000069885A2 (en) * | 1999-05-14 | 2000-11-23 | Millennium Pharmaceuticals, Inc. | Secreted proteins and uses thereof |
| WO2001066738A2 (en) * | 2000-03-06 | 2001-09-13 | Eli Lilly And Company | Nucleic acids, encoding human crsp1 and uses thereof |
-
2003
- 2003-06-13 WO PCT/US2003/018976 patent/WO2003105879A1/en not_active Ceased
- 2003-06-13 EP EP03737127A patent/EP1511506A4/en not_active Withdrawn
- 2003-06-13 US US10/515,892 patent/US20060210974A1/en not_active Abandoned
- 2003-06-13 JP JP2004512780A patent/JP2005529603A/ja active Pending
- 2003-06-13 AU AU2003238232A patent/AU2003238232A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105940300B (zh) | 检测高氨血症的装置和使用此类装置的方法 | |
| Inoue et al. | Sensitive detection of glycated albumin in human serum albumin using electrochemiluminescence | |
| CA2888743C (en) | Device and methods of using device for detection of aminoacidopathies | |
| CN103348015A (zh) | 用于分析物传感器的电极组合物 | |
| EP2812706A1 (en) | Assay and method for determining insulin-resistance | |
| JP2004531224A5 (enExample) | ||
| JP2005529603A5 (enExample) | ||
| Bessman et al. | Sugar Electrode Sensor for the | |
| JP2005528921A5 (enExample) | ||
| KR950704001A (ko) | 인간 세로토닌 수용체(5-ht_4b)를 암호화하는 dna 및 그 용도 | |
| JP2006503575A5 (enExample) | ||
| JP2005528080A5 (enExample) | ||
| JP2002515223A5 (enExample) | ||
| CN103267783A (zh) | 一种检测过氧化氢、尿酸或尿酸酶的方法 | |
| Xi et al. | Relationship between dilated cardiomyopathy and the E23K and I337V polymorphisms in the Kir6. 2 subunit of the K | |
| JP2006500002A5 (enExample) | ||
| JP2005525112A5 (enExample) | ||
| PRASAD | Glucagon-induced changes in the action potential, contraction, and Na+-K+-ATPase of cardiac muscle | |
| JP2005538930A5 (enExample) | ||
| JP2003514549A5 (enExample) | ||
| CN115181176A (zh) | RyR2基因突变、检测试剂盒、以及构建其动物模型的方法 | |
| CN111482090A (zh) | 一种智能响应性聚合物修饰的多孔膜材料及其制备方法和应用 | |
| JP2007515940A5 (enExample) | ||
| WO2003057827A3 (en) | Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes | |
| JP2003532369A5 (enExample) |